Maravai Lifesciences Holdings Inc

MRVI

NASDAQ. Currency in USD

25.82 +1.27 ( +5.17% )

Real time prices: September 23

Market Cap.
3.40B
Beta (5Y monthly)
-
Price/Earnings
11.83
EPS (TTM)
1.97
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
3.34M
1y Target Est.
58.12
Day's Range
24.24
-
25.90
52 Week's Range
19.83
-
49.95

Historical Summary

Performance
EPS growth
Share Buybacks

About Maravai Lifesciences Holdings Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.maravai.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
131.46M
Employees
550
Address
10770 Wateridge Circle, San Diego, CA, United States, 92121
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

Latest news

Owens & Minor (OMI) Q2 Earnings Meet Estimates
Owens & Minor (OMI) Q2 Earnings Meet Estimates

Owens & Minor (OMI) delivered earnings and revenue surprises of 0% and 3.31%, respectively, for...
By Zacks Investment Research - 7 weeks ago

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely...
By Zacks Investment Research - 7 weeks ago

Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Maravai LifeSciences Holdings, Inc. (MRVI) doesn't possess the right combination of the two key ingredients...
By Zacks Investment Research - 8 weeks ago

3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022

Each of these stocks is ready for a rebound.
By The Motley Fool - 9 weeks ago

Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie
Zacks Value Investor Highlights: Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie

Merck, Maravai LifeSciences, Sensus Healthcare, PetIQ and AbbVie have been highlighted in this Value Investor...
By Zacks Investment Research - 9 weeks ago

5 Cheap Healthcare Stocks in 2022
5 Cheap Healthcare Stocks in 2022

Looking for value stocks? Healthcare has been ignored over the last year.
By Zacks Investment Research - 9 weeks ago

Implied Volatility Surging for Maravai LifeSciences (MRVI) Stock Options
Implied Volatility Surging for Maravai LifeSciences (MRVI) Stock Options

Investors need to pay close attention to Maravai LifeSciences (MRVI) stock based on the movements...
By Zacks Investment Research - 10 weeks ago

TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team
TriLink BioTechnologies, part of Maravai LifeSciences, Expands R&D Leadership Team

Appoints Dr. Kate Broderick as Senior Vice President of Research and Development Appoints Dr. Kate...
By GlobeNewswire Inc. - 11 weeks ago